3-iodobenzylguanidine has been researched along with Extravascular Hemolysis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, K; Dopfer, R; Gillies, SD; Handgretinger, R; Klingebiel, T; Lang, P; Neithammer, D; Reisfeld, RA; Reuland, P; Schrappe, M | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Extravascular Hemolysis
| Article | Year |
|---|---|
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Child; Child, Preschool; Female; Gangliosides; Hemolysis; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Neuroblastoma; Radionuclide Imaging | 1995 |